Page last updated: 2024-12-05

allyl cyanide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

TL 350: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

allyl cyanide : An aliphatic nitrile that is hydrogen cyanide in which the hydrogen has been replaced by an allyl group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID8009
CHEBI ID183063
MeSH IDM0065108

Synonyms (50)

Synonym
STL301993
CHEBI:183063
3-butenenitrile
3-butenylnitrile
tl 350
allylnitrile
nsc-2583
wln: nc2u1
3-cyanopropene
vinylacetonitrile
3-butenonitrile
109-75-1
acetonitrile, vinyl-
1-butene-4-nitrile
nsc2583
.beta.-butenonitrile
propene-3-nitrile
3-cyano-1-propene
allyl cyanide
but-3-enenitrile
ai3-18438
nsc 2583
2-butenol-1
beta-butenonitrile
einecs 203-701-1
allylkyanid [czech]
inchi=1/c4h5n/c1-2-3-4-5/h2h,1,3h
allyl cyanide, 98%
A0227
AKOS000166696
ec 203-701-1
527u1wjj18 ,
unii-527u1wjj18
allylkyanid
EN300-56336
FT-0615266
allyl cyanide [mi]
allylcyanide
1-butene-3-nitrile
2-propenyl cyanide
1-propene-3-nitrile
ch2=chch2cn
DTXSID6021905
J-002325
mfcd00001962
3-butenenitrile, 9ci
vinyl-acetonitrile
beta -butenonitrile
Q1321290
H10716

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"5 LD50 doses of the nitriles by gavage and they were observed for 12 It for cholinomimetic and central nervous system effects."( Effect of dosing vehicle on the toxicity and metabolism of unsaturated aliphatic nitriles.
Farooqui, MY; Piper, J; Tamez, A; Ybarra, B,
)
0.13

Dosage Studied

ExcerptRelevanceReference
"00 mmol/kg, 2-PN), which exhibit long-term dyskinesia, was examined on the metabolism of serotonin (5-HT) and dopamine (DA) in five brain regions of mice 1, 5, 12 and 35 days after dosing with CRN or 2-PN or vehicle (0."( Alterations in the metabolism of serotonin and dopamine in the central nervous system of mice displaying a persistent dyskinesia due to crotononitrile or 2-pentenenitrile.
Hashimoto, K; Hayashi, M; Tanii, H, 1990
)
0.28
" Pretreatment with 5,7-dihydroxytryptamine (5,7-DHT) suppressed the allylnitrile-induced head twitching, and decreased the contents of 5-HT and 5-HIAA in almost all areas of the brain throughout the observation period, as well as the ratio of 5-HIAA/5-HT in the medulla oblongata plus pons from 1 to 30 days after dosing with allylnitrile."( Involvement of noradrenergic and 5-hydroxytryptaminergic systems in allylnitrile-induced head twitching.
Hashimoto, K; Huang, J; Tanii, H, 1993
)
0.29
"The effect of dosing vehicle on toxicity and metabolism of unsaturated aliphatic nitriles was investigated in male Sprague-Dawley rats."( Effect of dosing vehicle on the toxicity and metabolism of unsaturated aliphatic nitriles.
Farooqui, MY; Piper, J; Tamez, A; Ybarra, B,
)
0.13
" Rats in the high dosage groups exhibited a complete disappearance of the five waves of the auditory evoked-potentials."( The ototoxic effects induced in rats by treatment for 12 weeks with 2-butenenitrile, 3-butenenitrile and cis-2-pentenenitrile.
Ban, M; Gagnaire, F; Langlais, C; Marignac, B, 2001
)
0.31
" Mice in the lower dosage groups of 2, 20 and 200 micromol/kg exhibited no behavioral changes."( Allylnitrile: generation from cruciferous vegetables and behavioral effects on mice of repeated exposure.
Higashi, T; Leng, S; Saijoh, K; Takayasu, T; Tanii, H, 2004
)
0.32
" dosing schedule (2."( Butenenitriles have low axonopathic potential in the rat.
Boadas-Vaello, P; Cutillas, B; Llorens, J; Saldaña-Ruíz, S; Soler-Martín, C, 2011
)
0.37
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
neurotoxinA poison that interferes with the functions of the nervous system.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
antifeedantA substance that prevents pests from feeding.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
aliphatic nitrileAny nitrile derived from an aliphatic compound.
olefinic compoundAny organic molecular entity that contains at least one C=C bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (42)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (7.14)18.7374
1990's14 (33.33)18.2507
2000's11 (26.19)29.6817
2010's14 (33.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 46.22

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index46.22 (24.57)
Research Supply Index3.85 (2.92)
Research Growth Index5.06 (4.65)
Search Engine Demand Index62.34 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (46.22)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (6.52%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other43 (93.48%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]